Kansas Senator Roger Marshall announced the Ensuring Innovation Act, which is designed to lower prescription drug prices, has been signed by President Joe Biden.
Marshall says the goal here is to close loopholes that award “market exclusivity” to drugs that don’t represent true innovation for prescriptions, thus delaying cheaper generic drugs from reaching consumers.
Currently, the Food and Drug Administration gives so-called New Chemical Entities five years of exclusivity before generics can get to the market.
